| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09fa84c54c24536575f7f12c1f1db43 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-49 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 |
| filingDate |
1986-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f147dca7e4a541f8d24a720b893f0e4 |
| publicationDate |
1986-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0198321-A1 |
| titleOfInvention |
Medicament containing a plasminogen activator |
| abstract |
There will be a medicament containing a plasminogen activator from the group consisting of tissue plasminogen activator and its naturally occurring or synthetically or genetically engineered derivatives and a polysulfuric acid ester of a saccharide or a sulfated sugar, a method for producing such a medicament and its use for the treatment of Thromboses and embolisms are described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6051223-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0419252-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0419251-A1 |
| priorityDate |
1985-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |